David Apelian
Chief Executive Officer at EIGER BIOPHARMACEUTICALS, INC.
Net worth: 1 837 $ as of 2024-03-30
Profile
David Apelian is currently the Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. He previously served as the Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022.
Prior to that, he held positions at Bristol Myers Squibb Co. as the Clinical Director-Infectious Diseases Group from 2002 to 2004, and at Schering-Plough Corp.
as the Clinical Director-Hepatology Department from 1999 to 2002.
From 2013 to 2017, he was the Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. He also served as the Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013.
Additionally, he held a position as Vice President at Wyeth Pharmaceuticals LLC.
Dr. Apelian holds a doctorate degree from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA degree from Quinnipiac University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-11-19 | 367 ( 0.02% ) | 1 837 $ | 2024-03-30 |
David Apelian active positions
| Companies | Position | Start |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Chief Executive Officer | 2022-12-14 |
Former positions of David Apelian
| Companies | Position | End |
|---|---|---|
BlueSphere Bio, Inc.
 BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Chief Executive Officer | 2022-10-03 |
| ACHILLION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2017-12-27 |
| GLOBEIMMUNE, INC. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Chief Tech/Sci/R&D Officer | - |
Training of David Apelian
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Quinnipiac University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GLOBEIMMUNE, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- David Apelian
